Teva stock floundering the past ___ months, ___years. Acquisition of OPK only makes sense.
Look at any period for Teva stock 1 mo, 3 mo, YTD, 1 yr, 2 yr, anything. Behemoth needs opportunities. Frost has them stockpiled. Hope OPK has a chance to rise on its own for a year first as it should go north of $15 on its own.
Opko will not be bought out by anyone until we get several of the drugs we have in the pipeline approved and in the market and 4K Score is successful. Opko will then be a profitable company with growing sales and earnings of at least 30 percent a year and a market price over $30. This could be sometime in 2015 with a buyout price in the upper 30's. JMHO